Your doctor will review your medical history, underlying medical conditions, family medical history, medications, prior methods of weight loss, and your health goals
Experience safe, effective, and supportive care designed to help you reach your health goals with confidence
Metabolic: Euglycemic DKA The risk of euglycemic DKA is very uncommon, but its a clinically important and real complication to be aware of in patients using GLP-1 agonists
Its essential to do your research before consulting your doctor, as they may not provide this information upfront
doi:10.6061/clinics/2015(11)09
Publications on melanocortin receptor ligands indicate that synthetic -MSH analogues, including Melanotan II, have been developed as compounds with increased stability and more potent biological activity relative to natural melanocortin peptides